Literature DB >> 23066937

The impact of ADHD on the cognitive and academic functioning of children with NF1.

Natalie A Pride1, Jonathan M Payne, Kathryn N North.   

Abstract

We compared cognitive functioning, academic ability, and the predictors of academic underachievement in children with neurofibromatosis type 1 (NF1) (n = 132), children with NF1 and comorbid attention deficit hyperactivity disorder (NF1 + ADHD) (n = 60), and unaffected controls (n = 52). Results indicate the presence of ADHD burdens some aspects of cognitive functioning and learning in NF1. Inattention and executive dysfunction are general characteristics of the NF1 cognitive phenotype and significantly undermine academic achievement across children with NF1.

Entities:  

Mesh:

Year:  2012        PMID: 23066937     DOI: 10.1080/87565641.2012.695831

Source DB:  PubMed          Journal:  Dev Neuropsychol        ISSN: 1532-6942            Impact factor:   2.253


  22 in total

1.  Teaching reading to children with neurofibromatosis type 1: a clinical trial with random assignment to different approaches.

Authors:  Laura A Barquero; Angela M Sefcik; Laurie E Cutting; Sheryl L Rimrodt
Journal:  Dev Med Child Neurol       Date:  2015-04-22       Impact factor: 5.449

2.  Behavioral and cognitive outcomes for clinical trials in children with neurofibromatosis type 1.

Authors:  Thijs van der Vaart; André B Rietman; Ellen Plasschaert; Eric Legius; Ype Elgersma; Henriëtte A Moll
Journal:  Neurology       Date:  2015-10-30       Impact factor: 9.910

3.  The Impact of Neurofibromatosis Type 1 on the Health and Wellbeing of Australian Adults.

Authors:  Hilda A Crawford; Belinda Barton; Meredith J Wilson; Yemima Berman; Valerie J McKelvey-Martin; Patrick J Morrison; Kathryn N North
Journal:  J Genet Couns       Date:  2015-04-19       Impact factor: 2.537

4.  Educational delay and attainment in persons with neurofibromatosis 1 in Denmark.

Authors:  Karoline Doser; Line Kenborg; Elisabeth Wreford Andersen; Pernille Envold Bidstrup; Anja Kroyer; Hanne Hove; John Østergaard; Sven Asger Sørensen; Christoffer Johansen; John Mulvihill; Jeanette Falck Winther; Susanne Oksbjerg Dalton
Journal:  Eur J Hum Genet       Date:  2019-02-28       Impact factor: 4.246

5.  Neurocognitive outcomes in neurofibromatosis clinical trials: Recommendations for the domain of attention.

Authors:  Karin S Walsh; Jennifer Janusz; Pamela L Wolters; Staci Martin; Bonita P Klein-Tasman; Mary Anne Toledo-Tamula; Heather L Thompson; Jonathan M Payne; Kristina K Hardy; Peter de Blank; Claire Semerjian; Laura Schaffner Gray; Sondra E Solomon; Nicole Ullrich
Journal:  Neurology       Date:  2016-08-16       Impact factor: 9.910

6.  Quality of Life in Adults with Neurofibromatosis 1 in Brazil.

Authors:  Natália Parenti Bicudo; Balduíno Ferreira de Menezes Neto; Lucimar Retto da Silva de Avó; Carla Maria Ramos Germano; Débora Gusmão Melo
Journal:  J Genet Couns       Date:  2016-03-05       Impact factor: 2.537

Review 7.  Autism genetics: opportunities and challenges for clinical translation.

Authors:  Jacob A S Vorstman; Jeremy R Parr; Daniel Moreno-De-Luca; Richard J L Anney; John I Nurnberger; Joachim F Hallmayer
Journal:  Nat Rev Genet       Date:  2017-03-06       Impact factor: 53.242

8.  Neurofibromatosis type 1 and chronic neurological conditions in the United States: an administrative claims analysis.

Authors:  Chinwe C Madubata; Margaret A Olsen; Dustin L Stwalley; David H Gutmann; Kimberly J Johnson
Journal:  Genet Med       Date:  2014-06-05       Impact factor: 8.822

9.  Behavioral signatures related to genetic disorders in autism.

Authors:  Jacob As Vorstman; Patrick F Bolton; Hilgo Bruining; Marinus Jc Eijkemans; Martien Jh Kas; Sarah R Curran
Journal:  Mol Autism       Date:  2014-02-11       Impact factor: 7.509

10.  The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial.

Authors:  Laurence Lion-François; François Gueyffier; Catherine Mercier; Daniel Gérard; Vania Herbillon; Isabelle Kemlin; Diana Rodriguez; Tiphanie Ginhoux; Emeline Peyric; Virginie Coutinho; Valentine Bréant; Vincent des Portes; Stéphane Pinson; Patrick Combemale; Behrouz Kassaï
Journal:  Orphanet J Rare Dis       Date:  2014-09-10       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.